上海交通大学学报(医学版)

• 论著(基础研究) • 上一篇    下一篇

代谢型谷氨酸受体4通过Rab5抑制神经病理性痛

陈 锐,王 华,江 伟   

  1. 上海交通大学附属第六人民医院麻醉科, 上海 200233
  • 出版日期:2014-02-28 发布日期:2014-03-25
  • 通讯作者: 江 伟, 电子信箱: jiangw@sjtu.edu.cn。
  • 作者简介:陈 锐(1988—), 女, 硕士生; 电子信箱: cryourfriend@163.com。
  • 基金资助:

    国家自然科学基金青年科学基金(81100825)

Suppressive effect of metabotropic glutamate receptor 4 on neuropathic pain by Rab5

CHEN Rui, WANG Hua, JIANG Wei   

  1. Department of Anesthesiology, the Sixth People′s Hospital, Shanghai Jiao Tong University, Shanghai 200233, China
  • Online:2014-02-28 Published:2014-03-25
  • Supported by:

    Young Scientists Project of National Natural Science Foundation, 81100825

摘要:

目的 探讨代谢型谷氨酸受体4 (mGluR4)激活后抑制神经病理性痛的机制。方法 首先取24只SD大鼠,鞘内置管后随机分为空白对照组(n=6)、假手术组(n=6)和脊神经根结扎(SNL)组(n=12)。空白对照组只行鞘内置管术,其余大鼠均于术前和术后第1~6日测量50%机械缩足阈值(50%PWT);其次,将SNL组大鼠于术后第7日起,随机分为SNL+生理盐水组(n=6)和SNL+VU0155041组(n=6),分别予以鞘内注射生理盐水和VU0155041 (500 nmol)10 μL,2次/d×7 d,注药前和注药后30 min测量其50%PWT。最后,末次给药后1 h取空白对照组、SNL+生理盐水组和SNL+VU0155041组大鼠左侧脊髓腰膨大处送检基因芯片并利用Western blotting检测mGluR4及Rab5各亚型的表达变化。结果 SNL大鼠术后1~6 d其手术同侧后肢50%PWT较空白对照组及假手术组明显降低(P<0.01);SNL+VU0155041组大鼠手术同侧后肢50%PWT与SNL+生理盐水组相比自给药第4日起逐渐升高(P<0.01);Agilent表达谱基因芯片结果显示:SNL+生理盐水组的Rab5含量高于空白对照组,而空白对照组和SNL+VU0155041组相比无明显差异;Western blotting结果显示:SNL+生理盐水组的mGluR4表达明显低于空白对照组和SNL+VU0155041组(P<0.05),而Rab5A和Rab5C的表达明显高于空白对照组和SNL+VU0155041组(P<0.05),Rab5B在3组中的表达差异无统计学意义(P>0.05)。结论 mGluR4激活后可能是通过Rab5A和Rab5C调控突触囊泡递质释放从而影响神经病理性痛。

关键词: 代谢型谷氨酸受体4, Rab5, 神经病理性痛

Abstract:

Objective To explore the mechanism of neuropathic pain suppression by activating metabotropic glutamate receptor 4 (mGluR4). Methods Firstly, 24 SD rats were randomly divided into blank control group (n=6), shame operation group (n=6), and SNL group (n=12) after intrathecal catheterization. Rats in control group were only undergone the intrathecal catheterization. Values of 50%PWT were measured for other rats before surgery and 1~6 d after surgery. Then, rats in SNL group were randomly divided into SNL+saline group (n=6) and SNL+VU0155041 group (n=6) and received intrathecal injection of saline and VU0155041(500 nmol) 10 μL twice a day for seven days, respectively. Values of 50%PWT were measured before injection and 30 min after injection. Finally, left spinal dorsal horn of the spinal enlargement of control group, SNL+saline group and SNL+VU0155041group were obtained 1h after last injection and submitted for gene chip examination. The expression of mGluR4 and the subtypes of Rab5 were determined by Western blotting. Results During 1~6 d after surgery, values of 50%PWT of ipsilateral hindpaws in SNL group were significantly lower than those of the blank control group and shame operation group (P<0.01); the values of 50%PWT of the ipsilateral hindpaws in SNL+VU0155041 group were gradually higher than those of SNL+saline group from the forth day after injection (P<0.01); and the results of Agilent gene chip showed that Rab5 in SNL+saline group was higher than that of control group, while control group has no difference with SNL+VU0155041 group. The expression of mGluR4 in SNL+saline group was significantly lower than that of control group and SNL+VU0155041 group (P<0.05), but the expression of Rab5A and Rab5C were significantly higher than those of control group and SNL+VU0155041 group (P<0.05), and the differences of Rab5B expression among three groups were not statistically significant (P>0.05). Conclusion The activation of mGluR4 can affect neuropathic pain by regulating neurotransmitter release of synaptic vesicles through Rab5A and Ran5C.

Key words: metabotropic glutamate receptor 4, Rab5, neuropathic pain